CP and obesity due to melanocortin 4 receptor deficiency: Age over 70 years, smoking, obesity (BMI over 30), and diabetes are identified as significant independent predictors of 30-day mortality among hospitalized patients with severe COVID-19 pneumonia treated with CP infusion [35].